MPM BioImpact LLC holdings history

Add to watchlist

71 is the total number of securities MPM BioImpact LLC has owned. The longest MPM BioImpact LLC has owned a single stock is 15 quarters.

MPM BioImpact LLC historical holdings. Includes current and past holdings.
Period Weighting Quarter
TickerNameLongestShortestMin.Avg.Max.FirstLatest↓ Count
HARP Harpoon Therapeutics, ...15150.46%8.44%27.58%Q4 2019Q2 202315
RPTX Repare Therapeutics, Inc.14143.49%8.41%19.70%Q2 2020Q3 202314
TCRR TCR2 Therapeutics, Inc.14140.87%8.28%18.01%Q4 2019Q1 202314
ITOS iTeos Therapeutics, Inc.13134.66%10.00%15.66%Q3 2020Q3 202313
GTHX G1 Therapeutics, Inc.13130.92%4.31%13.34%Q4 2019Q4 202213
YMAB Y Mabs Therapeutics, Inc.12121.28%2.52%5.38%Q4 2019Q3 202212
CGEM Cullinan Oncology, Inc.111116.57%24.68%41.43%Q1 2021Q3 202311
EPZM Epizyme, Inc.11111.06%7.12%22.09%Q4 2019Q2 202211
ONCR Oncorus, Inc.11110.02%2.85%13.27%Q4 2020Q2 202311
NTLA Intellia Therapeutics,...910.60%3.86%5.54%Q4 2020Q3 202310
MRUS Merus N.V.10101.84%3.67%6.52%Q2 2020Q3 202210
HOWL Werewolf Therapeutics,...10101.27%3.22%6.84%Q2 2021Q3 202310
ADCT ADC Therapeutics, Inc.10100.38%2.07%6.72%Q2 2020Q3 202210
TPTX Turning Point Therapeu...992.36%4.56%8.42%Q1 2020Q1 20229
GERN Geron Corporation991.22%3.90%6.06%Q3 2021Q3 20239
CRNX Crinetics Pharmaceutic...990.97%1.95%3.80%Q3 2021Q3 20239
TVTX Travere Therapeutics Inc.991.15%1.62%1.92%Q3 2021Q3 20239
FOLD Amicus Therapeutics Inc.990.81%1.29%2.32%Q3 2021Q3 20239
RVMD Revolution Medicines, ...990.64%1.07%2.02%Q3 2021Q3 20239
INZY Inozyme Pharma Inc.990.06%0.41%0.88%Q3 2021Q3 20239
MEI Pharma, Inc.884.37%6.19%11.13%Q4 2019Q3 20218
AVRO AVROBIO, Inc.710.10%0.30%0.75%Q4 2020Q1 20238
BDTX Black Diamond Therapeu...710.07%0.16%0.33%Q4 2020Q1 20238
AXSM Axsome Therapeutics, Inc.430.56%1.09%1.75%Q3 2021Q3 20237
AVDL Avadel Pharmaceuticals...520.28%0.83%1.83%Q3 2021Q3 20237
PHAT Phathom Pharmaceutical...770.39%0.63%0.96%Q1 2022Q3 20237
IOVA Iovance Biotherapeutic...663.56%3.90%4.18%Q2 2022Q3 20236
RETA Reata Pharmaceuticals ...661.07%2.53%4.81%Q1 2022Q2 20236
MDGL Madrigal Pharmaceutica...660.69%1.54%2.27%Q2 2022Q3 20236
HRMY Harmony Biosciences Hl...660.90%1.52%1.99%Q3 2021Q4 20226
VERV Verve Therapeutics, Inc553.01%3.70%5.17%Q3 2022Q3 20235
RGNX REGENXBIO Inc.552.64%3.22%3.88%Q3 2022Q3 20235
CYTK Cytokinetics Inc.551.37%1.97%2.22%Q3 2021Q3 20225
BCRX Biocryst Pharmaceutica...551.57%1.94%2.79%Q3 2021Q3 20225
ARQT Arcutis Biotherapeutic...550.73%1.15%1.53%Q1 2022Q1 20235
MIRM Mirum Pharmaceuticals ...550.48%1.11%1.70%Q3 2021Q3 20225
VSTM Verastem, Inc.550.65%1.10%1.35%Q3 2021Q3 20225
EPIX ESSA Pharma, Inc.550.18%0.89%1.73%Q3 2021Q3 20225
AUTL Autolus Therapeutics L...550.06%0.13%0.19%Q4 2019Q4 20205
ISEE Iveric Bio Inc444.46%6.64%9.62%Q3 2022Q2 20234
INBX Inhibrx, Inc Com443.23%5.68%8.22%Q2 2022Q1 20234
PRVB Provention Bio Inc440.66%2.82%7.35%Q2 2022Q1 20234
INSM Insmed Incorporated441.77%2.43%3.56%Q4 2022Q3 20234
KRTX Karuna Therapeutics Inc220.68%1.53%2.40%Q1 2022Q3 20234
NEO Neogenomics Inc.440.31%0.69%1.12%Q3 2021Q2 20224
RLAY Relay Therapeutics Inc.333.04%3.90%5.24%Q1 2023Q3 20233
KDNY Chinook Therapeutics, ...330.54%3.17%7.76%Q4 2022Q2 20233
Moonlake Immunotherape...223.03%3.75%4.48%Q2 2023Q3 20232
QURE Uniqure N.V.221.82%3.68%5.53%Q4 2022Q1 20232
OLMA Olema Pharmaceuticals,...220.84%3.48%6.12%Q2 2023Q3 20232
CTMX CytomX Therapeutics, Inc.222.52%3.26%4.01%Q4 2019Q1 20202
Xeris Biopharma Holdin...221.98%2.04%2.10%Q2 2023Q3 20232
KALV Kalvista Pharmaceutica...221.38%1.43%1.49%Q2 2023Q3 20232
VRDN Viridian Therapeutics Inc221.05%1.13%1.22%Q2 2023Q3 20232
ADAP Adaptimmune Therapeuti...220.95%1.00%1.06%Q2 2023Q3 20232
EWTX Edgewise Therapeutics,...110.71%0.91%1.11%Q3 2022Q2 20232
ACAD Acadia Pharmaceuticals...220.53%0.76%0.99%Q4 2021Q1 20222
SNSS Sunesis Pharmaceutical...220.34%0.52%0.71%Q4 2019Q1 20202
ARQL ArQule, Inc.117.74%7.74%7.74%Q4 2019Q4 20191
MEIP MEI Pharma, Inc.116.01%6.01%6.01%Q4 2021Q4 20211
DCPH Deciphera Pharmaceutic...114.76%4.76%4.76%Q4 2019Q4 20191
ARGX argenx SE114.08%4.08%4.08%Q4 2019Q4 20191
STRUCTURE THERAPEUTICS...113.11%3.11%3.11%Q3 2023Q3 20231
CBAY CYMABAY THERAPEUTICS INC112.43%2.43%2.43%Q3 2023Q3 20231
MORF MORPHIC HOLDING INC111.22%1.22%1.22%Q3 2023Q3 20231
RLMD Relmada Therapeutics inc111.00%1.00%1.00%Q1 2022Q1 20221
VKTX VIKING THERAPEUTICS INC110.96%0.96%0.96%Q3 2023Q3 20231
LHDX Lucira Health Inc.110.68%0.68%0.68%Q3 2021Q3 20211
PRAX Praxis Precision Medic...110.38%0.38%0.38%Q4 2022Q4 20221
Harpoon Therapeutics, ...110.34%0.34%0.34%Q3 2023Q3 20231
Ventyx Biosciences Inc110.21%0.21%0.21%Q2 2023Q2 20231
 Download

The securities at the top of the list , including Harpoon Therapeutics, Inc., Repare Therapeutics, Inc., and TCR2 Therapeutics, Inc., are the highest-conviction holdings of MPM BioImpact LLC.

The conviction is calculated by counting the number of quarters a security has been reported by MPM BioImpact LLC. The higher the number, the higher the conviction and longer the holding period.

This page lists all the securities that MPM BioImpact LLC owns currently or has owned in the past.